YB-1, a new biomarker of glioma progression, is associated with the prognosis of glioma patients.

about

Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development.Positive expression of Y-box binding protein 1 and prognosis in non-small cell lung cancer: a meta-analysis.

P2860

Q41123932-5C3F3EE3-57E4-41AF-8ACF-E8A05901CD9C Q41547680-D9035062-C90B-4EDE-A788-3CE40C18E1FE

P2860

YB-1, a new biomarker of glioma progression, is associated with the prognosis of glioma patients.

Item

http://www.wikidata.org/entity/Q36949616

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

YB-1, a new biomarker of gliom ...... prognosis of glioma patients.

@en

type

Item

label

YB-1, a new biomarker of gliom ...... prognosis of glioma patients.

@en

prefLabel

YB-1, a new biomarker of gliom ...... prognosis of glioma patients.

@en

P1476

YB-1, a new biomarker of gliom ...... prognosis of glioma patients.

@en

P2093

Guangyue Li

http://www.w3.org/2001/XMLSchema#string

Huilin Gong

http://www.w3.org/2001/XMLSchema#string

Jiangwei Zhang

http://www.w3.org/2001/XMLSchema#string

Jin Zheng

http://www.w3.org/2001/XMLSchema#string

Weijiang Dong

http://www.w3.org/2001/XMLSchema#string

P2860

YB-1 as a potential target in cancer therapy

Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen.

Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockade.

Dual action of epidermal growth factor: extracellular signal-stimulated nuclear-cytoplasmic export and coordinated translation of selected messenger RNA

Humoral immune response induced by an engineered cell-based neuroblastoma vaccine with or without CD25 blockade.

Experimental approaches for the treatment of malignant gliomas.

Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients

Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

Genetics of adult glioma.

P304

318-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ABBS/GMW012

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26936129

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4886251

http://www.w3.org/2001/XMLSchema#string

YB-1, a new biomarker of glioma progression, is associated with the prognosis of glioma patients.

about

P2860

P2860

YB-1, a new biomarker of glioma progression, is associated with the prognosis of glioma patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932